Table 3.
Change in serum metabolic markers over 12 weeks in CAPABLE participants.
| Baseline |
Exit |
Change |
||||||
|---|---|---|---|---|---|---|---|---|
| Serum Marker | N | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | p-value |
| Glucose (mg/dL) | 21 | 90.7 | 82.4, 98.9 | 89.5 | 81.4, 97.6 | −1.2 | −4.7, 2.3 | 0.487 |
| HbA1c (%) | 20 | 5.7 | 5.3, 6.0 | 5.3 | 5.1, 5.6 | −0.4 | −0.5, −0.2 | <0.001 |
| Total Cholesterol (mg/dL) | 21 | 190.7 | 174.9, 206.4 | 189.8 | 174.0, 205.6 | −0.9 | −8.8, 7.1 | 0.824 |
| Triglycerides (mg/dL) | 21 | 99.0 | 80.4, 117.7 | 85.4 | 66.7, 104.1 | −13.7 | −30.4, 3.1 | 0.105 |
| HDL (mg/dL) | 21 | 62.4 | 54.6, 70.2 | 63.0 | 56.1, 69.8 | 0.6 | −2.6, 3.7 | 0.711 |
| LDL (mg/dL) | 17 | 108.5 | 93.6, 123.3 | 118.1 | 102.2, 134.0 | 1.3 | −6.6, 9.2 | 0.734 |
| VLDL (mg/dL) | 16 | 19.8 | 15.9, 23.7 | 18.7 | 14.5, 23.0 | −2.3 | −6.7, 2.2 | 0.298 |
*4 participants had recorded Triglyceride levels < 50 mg/dL and therefore LDL and VLDL results were unavailable.